Cancer Research & Treatment Fund, Inc. (CR&T) funds research emphasizing the cause, prevention, treatment, and cure of myeloproliferative neoplasms (MPNs) and also funds other blood and solid tumor cancer research.
Expanding CR&T's Impact
Since 1968, CR&T is proud to have maintained our mission to fund research emphasizing the cause, prevention, treatment and cure of MPN.
Read More
CR&T Honors Dr Richard T. Silver with its Humanitarian Award